Nicolas Pauillac
Stock Analyst at Kepler Capital
(4.67)
# 781
Out of 4,345 analysts
377
Total ratings
55.2%
Success rate
16.6%
Average return
Main Sectors:
Stocks Rated by Nicolas Pauillac
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Upgraded: Buy | 1,500p → 2,516p | $1,939.50 | +29.72% | 2 | May 26, 2026 | |
| SWX: COPN Cosmo N.V. | Maintained: Buy | CHF 130.00 | $80.40 | +61.69% | 35 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Maintained: Buy | CHF 80.00 | $64.52 | +23.99% | 29 | May 11, 2026 | |
| EPA: CVX Carvolix SA | Maintained: Buy | €5.00 | $3.04 | +64.47% | 30 | May 4, 2026 | |
| EPA: OSE OSE Immunotherapeutics SA | Maintained: Buy | €8.20 | $4.71 | +74.10% | 40 | Apr 30, 2026 | |
| SWX: IDIA Idorsia Ltd | Maintained: Buy | CHF 4.50 | $4.49 | +0.31% | 1 | Apr 28, 2026 | |
| SWX: BION BB Biotech AG | Maintained: Buy | CHF 66.00 → CHF 73.00 | $44.45 | +64.23% | 15 | Apr 24, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €85.00 | $77.14 | +10.19% | 16 | Apr 23, 2026 | |
| ETR: FYB Formycon AG | Maintained: Buy | €33.00 | $20.25 | +62.96% | 51 | Apr 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 280.00 | $285.40 | -1.89% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €20.30 | $15.78 | +28.64% | 34 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €36.60 | $26.68 | +37.18% | 33 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €5.00 | $2.91 | +71.82% | 8 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €15.00 | $10.48 | +43.13% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €390.00 | $363.50 | +7.29% | 19 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €0.80 → €0.64 | $0.02 | n/a | 21 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $48 | $27.70 | n/a | 2 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €79.00 → €41.00 | $24.20 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $397 → $435 | $821.37 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €342.00 → €375.00 | $702.93 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.82 | n/a | 3 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 57.00 | $53.50 | n/a | 10 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | $2.81 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €7.50 → €9.00 | $2.69 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €17.00 | $4.91 | n/a | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €0.60 → €0.40 | $0.19 | n/a | 4 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €2.70 | $0.392 | n/a | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | $4.94 | n/a | 1 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | $112.40 | n/a | 1 | Dec 21, 2022 |
GSK plc
May 26, 2026
Upgraded: Buy
Price Target: 1,500p → 2,516p
Current: $1,939.50
Upside: +29.72%
Cosmo N.V.
May 11, 2026
Maintained: Buy
Price Target: CHF 130.00
Current: $80.40
Upside: +61.69%
Sandoz Group AG
May 11, 2026
Maintained: Buy
Price Target: CHF 80.00
Current: $64.52
Upside: +23.99%
Carvolix SA
May 4, 2026
Maintained: Buy
Price Target: €5.00
Current: $3.04
Upside: +64.47%
OSE Immunotherapeutics SA
Apr 30, 2026
Maintained: Buy
Price Target: €8.20
Current: $4.71
Upside: +74.10%
Idorsia Ltd
Apr 28, 2026
Maintained: Buy
Price Target: CHF 4.50
Current: $4.49
Upside: +0.31%
BB Biotech AG
Apr 24, 2026
Maintained: Buy
Price Target: CHF 66.00 → CHF 73.00
Current: $44.45
Upside: +64.23%
Sanofi
Apr 23, 2026
Maintained: Hold
Price Target: €85.00
Current: $77.14
Upside: +10.19%
Formycon AG
Apr 22, 2026
Maintained: Buy
Price Target: €33.00
Current: $20.25
Upside: +62.96%
Novo Nordisk A/S
Apr 20, 2026
Maintained: Hold
Price Target: kr 280.00
Current: $285.40
Upside: -1.89%
Apr 1, 2026
Maintained: Buy
Price Target: €20.30
Current: $15.78
Upside: +28.64%
Mar 6, 2026
Maintained: Buy
Price Target: €36.60
Current: $26.68
Upside: +37.18%
Feb 25, 2026
Maintained: Buy
Price Target: €5.00
Current: $2.91
Upside: +71.82%
Sep 25, 2025
Maintained: Hold
Price Target: €15.00
Current: $10.48
Upside: +43.13%
Jul 17, 2025
Maintained: Hold
Price Target: €390.00
Current: $363.50
Upside: +7.29%
May 6, 2024
Maintained: Sell
Price Target: €0.80 → €0.64
Current: $0.02
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $92 → $48
Current: $27.70
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: €79.00 → €41.00
Current: $24.20
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: $397 → $435
Current: $821.37
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: €342.00 → €375.00
Current: $702.93
Upside: n/a
Jan 10, 2024
Maintained: Buy
Price Target: $14
Current: $2.82
Upside: n/a
Nov 20, 2023
Maintained: Buy
Price Target: CHF 57.00
Current: $53.50
Upside: n/a
Sep 7, 2023
Maintained: Buy
Price Target: €16.00
Current: $2.81
Upside: n/a
Aug 28, 2023
Upgraded: Buy
Price Target: €7.50 → €9.00
Current: $2.69
Upside: n/a
Jun 22, 2023
Maintained: Buy
Price Target: €17.00
Current: $4.91
Upside: n/a
May 3, 2023
Maintained: Buy
Price Target: €0.60 → €0.40
Current: $0.19
Upside: n/a
Apr 28, 2023
Maintained: Buy
Price Target: €2.70
Current: $0.392
Upside: n/a
Dec 29, 2022
Maintained: Buy
Price Target: €12.00
Current: $4.94
Upside: n/a
Dec 21, 2022
Maintained: Buy
Price Target: €16.00
Current: $112.40
Upside: n/a